National Cancer Institute (NCI)

SEP 9, 2026 · PHASE 2 TRIAL

Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 2 trial registry record with no results posted; the study is active but not recruiting, and outcome data are not yet reported in this source.

SEP 9, 2026 · PHASE 1/2 TRIAL

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

ClinicalTrials.gov

This is a Phase 1/2 trial registration with no results posted; it describes planned enrollment and endpoints only, without efficacy or safety outcomes, making it an early-stage design document rather than evidence of clinical benefit.

SEP 8, 2026 · PHASE 1/2 TRIAL

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 1/2 trial registration with recruitment suspended; no results are posted, making it an early-stage study design record without outcome data.

SEP 8, 2026 · OBSERVATIONAL STUDY

Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies

ClinicalTrials.gov

This is a prospective observational tissue repository and biobank study with no results reported; it documents planned enrollment and collection procedures for future genomic research.

SEP 4, 2026 · OBSERVATIONAL STUDY

BRCA Mutations in Latinas

ClinicalTrials.gov

This is a completed observational registry study with no posted results; it describes enrollment and biospecimen collection methodology only, without outcome data or analysis.

SEP 4, 2026 · PHASE 3 TRIAL

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

ClinicalTrials.gov

This is an actively recruiting Phase 3 trial with no results posted; the registry record describes planned design and enrollment only, with no outcome data available for assessment.

SEP 4, 2026 · PHASE 2 TRIAL

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 2 trial registration with no results posted; it describes a planned interventional study testing TRC102 added to chemoradiotherapy in stage III NSCLC, designed to assess feasibility and signal before larger trials.

AUG 20, 2026 · PHASE 2 TRIAL

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

ClinicalTrials.gov

This is a Phase 2 trial still recruiting with no results posted; it represents early-phase investigation of lutetium Lu 177 dotatate versus everolimus in bronchial neuroendocrine tumors.